Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre D Delmas

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Lancet (London, England)|June 22, 2002
Treatment of postmenopausal osteoporosisPierre D Delmas
Current Opinion in Rheumatology|June 16, 2005
The use of bisphosphonates in the treatment of osteoporosisPierre D Delmas
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 4, 2004
Clinical effects of strontium ranelate in women with postmenopausal osteoporosisPierre D Delmas
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|April 1, 2008
Clinical potential of RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseasesPierre D Delmas
Endocrinology and Metabolism Clinics of North America|April 18, 2003
Selective estrogen receptors modulators in the prevention and treatment of postmenopausal osteoporosisAurelie Fontana, Pierre D Delmas
Current Opinion in Rheumatology|September 10, 2003
Biomarkers in osteoarthritisPatrick Garnero, Pierre D Delmas
La Revue Du Praticien|February 24, 2005
[Treatment of postmenopausal osteoporosis]Roland Chapurlat, Pierre D Delmas
Presse Medicale (Paris, France : 1983)|December 20, 2002
[Osteoporosis in the aged male]Pawel Szulc, Pierre D Delmas
Bone|March 31, 2004
Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapyPierre D Delmas, Ego Seeman
Current Opinion in Rheumatology|June 18, 2004
Noninvasive techniques for assessing skeletal changes in inflammatory arthritis: bone biomarkersPatrick Garnero, Pierre D Delmas
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Lancet (London, England)|June 22, 2002
Treatment of postmenopausal osteoporosisPierre D Delmas
Current Opinion in Rheumatology|June 16, 2005
The use of bisphosphonates in the treatment of osteoporosisPierre D Delmas
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 4, 2004
Clinical effects of strontium ranelate in women with postmenopausal osteoporosisPierre D Delmas
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|April 1, 2008
Clinical potential of RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseasesPierre D Delmas
Endocrinology and Metabolism Clinics of North America|April 18, 2003
Selective estrogen receptors modulators in the prevention and treatment of postmenopausal osteoporosisAurelie Fontana, Pierre D Delmas
Current Opinion in Rheumatology|September 10, 2003
Biomarkers in osteoarthritisPatrick Garnero, Pierre D Delmas
La Revue Du Praticien|February 24, 2005
[Treatment of postmenopausal osteoporosis]Roland Chapurlat, Pierre D Delmas
Presse Medicale (Paris, France : 1983)|December 20, 2002
[Osteoporosis in the aged male]Pawel Szulc, Pierre D Delmas
Bone|March 31, 2004
Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapyPierre D Delmas, Ego Seeman
Current Opinion in Rheumatology|June 18, 2004
Noninvasive techniques for assessing skeletal changes in inflammatory arthritis: bone biomarkersPatrick Garnero, Pierre D Delmas
Pageof 12